Stocks
Kodiak Sciences Inc.KOD
NASDAQHealthcareBiotechnology$23.19-2.52%
A clinical-stage biotechnology company developing therapies for retinal diseases such as wet age-related macular degeneration and diabetic retinopathy. Its pipeline centers on antibody-based drug candidates designed to provide longer-lasting treatment for chronic eye conditions, with lead programs a...
Market Cap: $1.2B52W Range: $1.92 – $31.18
Congressional Interest in Kodiak Sciences Inc. (KOD)
2 members of Congress have disclosed 3 trades in Kodiak Sciences Inc. (KOD), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
2
Sells
1
Who in Congress Is Trading KOD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-01-31 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |